FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285118867> ?p ?o ?g. }

• W4285118867 endingPage "08007" @default.
• W4285118867 startingPage "08007" @default.
• W4285118867 abstract "Main text Under the auspices of the Protein Analysis Working Group (PAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a pilot study, CCQM-P55.2.c, was coordinated by the Bureau International des Poids et Mesures (BIPM), the Health Sciences Authority (HSA) of Singapore and the Chinese National Institute of Metrology (NIM). Three Metrology Institutes or Designated Institutes and the BIPM participated. Participants were required to assign the mass fraction of glycated hexapeptide of HbA1c (GE) present as the main component in the comparison sample for CCQM-P55.2.c. The comparison samples were prepared by HSA/BIPM from synthetic GE purchased from a commercial supplier and used as provided without further treatment or purification. GE was selected to be representative of the performance of a laboratory's measurement capability for the purity assignment of chemically synthesized peptides of known sequence, without cross-links, up to 5 kDa and modification (mono-glycation). It was anticipated to provide an analytical measurement challenge representative for the value-assignment of compounds of broadly similar structural characteristics. The majority of participants used amino acid analysis (PICAA) or quantitative nuclear magnetic resonance (PICqNMR) spectroscopy with a correction for structurally-related peptide impurities. It was decided to assign reference values (RVs) based on the KCRVs of CCQM-K115.c for both the GE mass fraction and the mass fraction of the peptide related impurities as indispensable contributor regardless of the use of PICAA, mass balance or any other approach to determine the GE purity. This allowed participants to demonstrate the efficacy of their implementation of the approaches used to determine the GE mass fraction. In particular, it allows participants to demonstrate the efficacy of their implementation of peptide related impurity identification and quantification. More detailed studies on the identification/quantification of peptide related impurities revealed that the integrity of the impurity profile of the related peptide impurities obtained by the participant is crucial for the impact on accuracy of the GE mass fraction assignment. The assessment of the mass fraction of peptide impurities is based on the assumption that all results are directly taken for the calculation of the RV PepImp by use of random-effects meta-analysis (DerSimonian-Laird (DSL) variance-weighted mean). The RV PepImp of 45.4 mg/g is associated with a corresponding expanded uncertainty of 9.5 mg/g (k =2.26) providing a more realistic basis of evaluation for the capabilities of the participants to identify/quantify peptide related impurities. Inspection of the degree of equivalence plots for the mass fraction of peptide impurities and additional information obtained from the peptide related impurity profile indicates that in all cases the major related peptide impurities have been identified and quantified. The approach selected to obtain a RV GE for the mass fraction of GE is based on the DerSimonian-Laird (DSL) variance-weighted mean. The DSL mean takes into account the uncertainties of the results while introducing sufficient excess variance to allow for their observed dispersion resulting in a larger expanded uncertainty U(RV GE ). The RV GE based on CCQM-K115.c is 628 mg/g with a corresponding expanded uncertainty of the RV GE of 27 mg/g (k =2.26). All GE mass fraction results are in agreement with the RV GE . To reach the main text of this paper, click on Final Report . Note that this text is that which appears in Appendix B of the BIPM key comparison database https://www.bipm.org/kcdb/ . The final report has been peer-reviewed and approved for publication by the CCQM, according to the provisions of the CIPM Mutual Recognition Arrangement (CIPM MRA)." @default.
• W4285118867 created "2022-07-14" @default.
• W4285118867 creator A5001625417 @default.
• W4285118867 creator A5010227961 @default.
• W4285118867 creator A5015204254 @default.
• W4285118867 creator A5016363207 @default.
• W4285118867 creator A5016962306 @default.
• W4285118867 creator A5018376095 @default.
• W4285118867 creator A5020376382 @default.
• W4285118867 creator A5023501494 @default.
• W4285118867 creator A5025102482 @default.
• W4285118867 creator A5026147542 @default.
• W4285118867 creator A5029213898 @default.
• W4285118867 creator A5032456042 @default.
• W4285118867 creator A5045107260 @default.
• W4285118867 creator A5045722282 @default.
• W4285118867 creator A5046249545 @default.
• W4285118867 creator A5046254969 @default.
• W4285118867 creator A5053328711 @default.
• W4285118867 creator A5056723899 @default.
• W4285118867 creator A5057470169 @default.
• W4285118867 creator A5058595001 @default.
• W4285118867 creator A5060296467 @default.
• W4285118867 creator A5061129549 @default.
• W4285118867 creator A5061558304 @default.
• W4285118867 creator A5065334205 @default.
• W4285118867 creator A5066656633 @default.
• W4285118867 creator A5067707959 @default.
• W4285118867 creator A5070220231 @default.
• W4285118867 creator A5077105471 @default.
• W4285118867 creator A5079738744 @default.
• W4285118867 creator A5079817417 @default.
• W4285118867 creator A5080243616 @default.
• W4285118867 creator A5081897868 @default.
• W4285118867 creator A5085380003 @default.
• W4285118867 creator A5085765462 @default.
• W4285118867 creator A5087533245 @default.
• W4285118867 creator A5088860366 @default.
• W4285118867 date "2022-01-01" @default.
• W4285118867 modified "2023-09-28" @default.
• W4285118867 title "Pilot study on peptide purity - glycated hexapeptide of HbA1c" @default.
• W4285118867 doi "https://doi.org/10.1088/0026-1394/59/1a/08007" @default.
• W4285118867 hasPublicationYear "2022" @default.
• W4285118867 type Work @default.
• W4285118867 citedByCount "1" @default.
• W4285118867 countsByYear W42851188672023 @default.
• W4285118867 crossrefType "journal-article" @default.
• W4285118867 hasAuthorship W4285118867A5001625417 @default.
• W4285118867 hasAuthorship W4285118867A5010227961 @default.
• W4285118867 hasAuthorship W4285118867A5015204254 @default.
• W4285118867 hasAuthorship W4285118867A5016363207 @default.
• W4285118867 hasAuthorship W4285118867A5016962306 @default.
• W4285118867 hasAuthorship W4285118867A5018376095 @default.
• W4285118867 hasAuthorship W4285118867A5020376382 @default.
• W4285118867 hasAuthorship W4285118867A5023501494 @default.
• W4285118867 hasAuthorship W4285118867A5025102482 @default.
• W4285118867 hasAuthorship W4285118867A5026147542 @default.
• W4285118867 hasAuthorship W4285118867A5029213898 @default.
• W4285118867 hasAuthorship W4285118867A5032456042 @default.
• W4285118867 hasAuthorship W4285118867A5045107260 @default.
• W4285118867 hasAuthorship W4285118867A5045722282 @default.
• W4285118867 hasAuthorship W4285118867A5046249545 @default.
• W4285118867 hasAuthorship W4285118867A5046254969 @default.
• W4285118867 hasAuthorship W4285118867A5053328711 @default.
• W4285118867 hasAuthorship W4285118867A5056723899 @default.
• W4285118867 hasAuthorship W4285118867A5057470169 @default.
• W4285118867 hasAuthorship W4285118867A5058595001 @default.
• W4285118867 hasAuthorship W4285118867A5060296467 @default.
• W4285118867 hasAuthorship W4285118867A5061129549 @default.
• W4285118867 hasAuthorship W4285118867A5061558304 @default.
• W4285118867 hasAuthorship W4285118867A5065334205 @default.
• W4285118867 hasAuthorship W4285118867A5066656633 @default.
• W4285118867 hasAuthorship W4285118867A5067707959 @default.
• W4285118867 hasAuthorship W4285118867A5070220231 @default.
• W4285118867 hasAuthorship W4285118867A5077105471 @default.
• W4285118867 hasAuthorship W4285118867A5079738744 @default.
• W4285118867 hasAuthorship W4285118867A5079817417 @default.
• W4285118867 hasAuthorship W4285118867A5080243616 @default.
• W4285118867 hasAuthorship W4285118867A5081897868 @default.
• W4285118867 hasAuthorship W4285118867A5085380003 @default.
• W4285118867 hasAuthorship W4285118867A5085765462 @default.
• W4285118867 hasAuthorship W4285118867A5087533245 @default.
• W4285118867 hasAuthorship W4285118867A5088860366 @default.
• W4285118867 hasConcept C105795698 @default.
• W4285118867 hasConcept C113196181 @default.
• W4285118867 hasConcept C116628846 @default.
• W4285118867 hasConcept C126322002 @default.
• W4285118867 hasConcept C144133560 @default.
• W4285118867 hasConcept C155202549 @default.
• W4285118867 hasConcept C162356407 @default.
• W4285118867 hasConcept C178790620 @default.
• W4285118867 hasConcept C185592680 @default.
• W4285118867 hasConcept C195766429 @default.
• W4285118867 hasConcept C2985213535 @default.
• W4285118867 hasConcept C2993070364 @default.
• W4285118867 hasConcept C2993899435 @default.
• W4285118867 hasConcept C33923547 @default.
• W4285118867 hasConcept C43617362 @default.

• next